Key result
Pharmacologic management of the systemic right ventricle, such as with ACE inhibitors, is based on limited clinical experience but follows principles similar to left ventricular failure.
The authors suggest that pharmacologic management of the systemic right ventricle, such as using ACE inhibitors, should be guided by principles similar to those for congestive left ventricular failure.
To the Editor We thank the correspondents for their insightful comments1 regarding the benefits of pharmacotherapy in selected patients with systemic right ventricles. The underlying principles of pharmacologic management of the systemic right ventricle are necessarily based on less than robust clinical experience, but are probably similar to those guiding management of congestive left ventricular failure. Therefore, we also use ACE inhibitors for …
No takes yet. Share an insight, caveat, or question.
Kutty et al. (2018) conducted a letter in Systemic right ventricle. Pharmacotherapy (e.g., ACE inhibitors) was evaluated. Pharmacologic management of the systemic right ventricle, such as with ACE inhibitors, is based on limited clinical experience but follows principles similar to left ventricular failure.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: